Evotec SE (EVO) EBITDA (2009 - 2025)

Evotec SE has disclosed EBITDA across 9 years of filings, most recently posting $67514.5 for Q4 2025.

• In Q4 2025, EBITDA rose 121.69% year-over-year to $67514.5; the TTM figure through Dec 2025 stood at -$72.9 million (up 48.54% YoY), while the FY2025 annual figure was $60106.0, up 145.72% from the prior year.
• EBITDA came in at $67514.5 for Q4 2025 at Evotec SE, up from -$52.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $20.9 million in Q3 2021 to a low of -$112.6 million in Q2 2024.
• Average EBITDA over 5 years is -$11.8 million, with a median of $21169.5 recorded in 2022.
• Year-over-year, EBITDA plunged 217435.46% in 2022 and surged 72554.4% in 2025.
• Over 5 years, EBITDA stood at $80176.3 in 2021, then plunged by 43.25% to $45503.0 in 2022, then rose by 18.73% to $54024.0 in 2023, then slumped by 43.63% to $30455.0 in 2024, then jumped by 121.69% to $67514.5 in 2025.
• Per Business Quant data, the three most recent EBITDA figures were $67514.5 in Q4 2025, -$52.0 million in Q3 2025, and -$31.4 million in Q2 2025.